Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Flumethrin (85%)
Elanco GmbH
QP53AC05
Flumethrin (85%)
3.6 milligram/strip
Bee-hive strip
LM: Licensed Merchant as defined in relevant national legislation
flumethrin
Authorised
2006-09-21
Health Products Regulatory Authority 01 July 2021 CRN00C4TD Page 1 of 4 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Bayvarol 3.6 mg Bee-Hive Strips for honey bees 2 QUALITATIVE AND QUANTITATIVE COMPOSITION One Bee-hive strip contains: ACTIVE SUBSTANCES Flumethrin (85%) 4.23 mg (Equivalent to 3.6 mg Flumethrin 100%) For the full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Bee-hive strips. Milky white plastic strips. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Honeybees. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the diagnosis and control of flumethrin sensitive _Varroa destructor _in honeybees. 4.3 CONTRAINDICATIONS None. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES All colonies located on the same apiary should be treated simultaneously. The product should be used as part of an integrated Varroa control programme. Such programme includes, among other measures, rotation of products and systematic monitoring of mite burden during the year. As an effective method to reduce the risk of resistance selection, rotation with products containing active substances from other chemical classes should be applied. As flumethrin and tau-fluvalinate belong to the same class ("pyrethroids") they are not suitable for rotation with each other. Inappropriate use of the product may increase the risk of resistance development and ultimately result in ineffective therapy and colony losses. Bee colonies should be monitored routinely to check the level of mite infestation (Varroa) (e.g., with established standard tests like continuous monitoring of natural mite fall using a sticky insert tray or assessing mite load per 100 bees). In the case of existing resistance to pyrethroids, Bayvarol Strips should not be applied. Where resistance to pyrethroids has been seen in the past, retesting of the current status of the colony may be considered, as reversion to susceptibility can occur over several years. 4.5 SPECIAL PRECAUTIONS FOR USE I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS None Read the complete document